SPY330.06+1.27 0.39%
DIA268.41+1.69 0.63%
IXIC10,941.17+38.37 0.35%

Neon Therapeutics Q3 EPS $(0.68) Down From $(0.67) YoY

Neon Therapeutics (NASDAQ:NTGN) reported quarterly losses of $(0.68) per share. This is a 1.49 percent decrease over losses of $(0.67) per share from the same period last year.

Benzinga · -

Neon Therapeutics (NASDAQ:NTGN) reported quarterly losses of $(0.68) per share. This is a 1.49 percent decrease over losses of $(0.67) per share from the same period last year.